GURU.Markets stock price, segment price, and overall market index valuation
The company's share price DaVita Inc.
DaVita is one of the two dominant dialysis providers in the United States. Its stock price is driven by the demographics of an aging population, government healthcare rates, and its ability to effectively manage its extensive network of clinics. It is a stable, regulated business.
Share prices of companies in the market segment - Treatment
DaVita is a leader in the dialysis services segment, managing a network of clinics for patients with kidney failure. We classify the company in the Healthcare Institutions sector. The graph below shows the dynamics of this segment, which are influenced by demographics and government healthcare policy.
Broad Market Index - GURU.Markets
DaVita is one of the largest providers of dialysis services for patients with chronic kidney failure in the United States. Its stable and vital business earns it a spot in the GURU.Markets index. The chart below shows how the company's shares perform against the broader market.
Change in the price of a company, segment, and market as a whole per day
DVA - Daily change in the company's share price DaVita Inc.
The daily price change for DaVita, the largest operator of dialysis centers, reveals its response to healthcare policy. The graph of these fluctuations is unspectacular, but it is a critical component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Treatment
DaVita Inc. is one of the largest dialysis center operators. This chart shows the average daily volatility of the healthcare sector. Comparison with the DVA dynamics helps assess its sensitivity to government treatment tariffs and demographic trends.
Daily change in the price of a broad market stock, index - GURU.Markets
DaVita is one of the largest dialysis center operators in the US. Demand for its services is supported by demographic trends. The chart below shows overall market volatility, which may make DaVita, as part of the healthcare sector, appear more secure.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization DaVita Inc.
DaVita is the market leader in dialysis services in the US. Its year-over-year growth reflects stable demand driven by the growing number of patients with kidney failure. The chart below tells the story of this resilient, yet highly regulated, medical business.
Annual dynamics of market capitalization of the market segment - Treatment
DaVita Inc. is one of the two dominant dialysis providers in the United States. Its business is fueled by the chronic nature of kidney failure. The chart shows how demographic trends, government regulations, and operational efficiency influence its performance in the healthcare sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
DaVita provides vital dialysis services for which demand is inelastic. It's a classic example of a defensive stock, whose stock performance is weakly dependent on economic cycles. A comparison with the market shows how the company appears to be an island of stability during recessions, while during periods of market euphoria it can exhibit more restrained growth.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization DaVita Inc.
DaVita, one of the largest dialysis center operators in the US, operates in a stable healthcare sector. The monthly fluctuations in the chart reflect the steadily increasing number of kidney failure patients and reimbursement rates from public and private insurers.
Monthly dynamics of market capitalization of the market segment - Treatment
This chart shows the dynamics of the healthcare services sector, specifically dialysis centers, where DaVita is one of two dominant players. Its movements reflect stable demand for its vital services and changes in government reimbursement programs (Medicare).
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
DaVita, a leader in kidney failure treatment, operates in the non-cyclical healthcare sector. The need for dialysis is constant, giving the company's stock a defensive nature. Its performance often bears little relation to overall market fluctuations, as can be seen in the chart.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization DaVita Inc.
DaVita is one of the largest dialysis center operators in the United States. The company's weekly stock price is heavily dependent on government decisions regarding Medicare reimbursement rates, which account for a significant portion of its revenue.
Weekly dynamics of market capitalization of the market segment - Treatment
DaVita is one of two dominant players in the US dialysis center market. Comparing its weekly performance with the healthcare sector reveals the uniqueness of its business. The chart shows how government decisions on Medicare rates cause its shares to move at a different pace than the rest of the industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
DaVita, a dialysis center operator, operates a business that is unaffected by economic cycles. Comparing its weekly performance with the broader market will highlight its defensive properties. The chart shows how the company's shares demonstrate stability during periods of market volatility, as its services are always in demand.
Market capitalization of the company, segment and market as a whole
DVA - Market capitalization of the company DaVita Inc.
The DaVita market capitalization chart is a visualization of the economics of the US dialysis industry. The dynamics of one of the two dominant dialysis providers reflects an aging population and rising diabetes rates, as well as risks associated with changes in government reimbursement programs such as Medicare.
DVA - Share of the company's market capitalization DaVita Inc. within the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure in the United States. The company's market share in the healthcare sector reflects its dominant position in this vital market. The chart below demonstrates DaVita's enormous and consistent influence in the healthcare system.
Market capitalization of the market segment - Treatment
DaVita is one of the largest providers of dialysis services for patients with kidney failure in the United States. The chart below shows the overall market capitalization of the treatment sector. Its stable growth is driven by the chronic nature of the disease and an aging population, which provides the company with a predictable flow of patients.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart illustrates a business focused on a vital procedure. DaVita is a leader in dialysis services in the United States. Its market capitalization is based on consistent and growing demand driven by demographic and medical trends. It's a visualization of how chronic disease treatment creates a powerful and predictable business.
Book value capitalization of the company, segment and market as a whole
DVA - Book value capitalization of the company DaVita Inc.
DaVita's capital is its vast network of dialysis centers. Its book value directly reflects the value of this medical infrastructure, which includes thousands of clinics across the country. The chart below is a visual history of how the company built its dominant network by acquiring and opening new centers to provide vital medical care.
DVA - Share of the company's book capitalization DaVita Inc. within the market segment - Treatment
DaVita is a leader in kidney failure treatment. Its business consists of a vast network of thousands of dialysis centers across the country. The chart clearly demonstrates the significant share of the physical medical infrastructure required to provide these vital services that the company controls.
Market segment balance sheet capitalization - Treatment
DaVita, a leader in dialysis services, operates a highly capital-intensive business. This requires owning thousands of clinics equipped with expensive medical equipment. The BCap_Seg chart for the healthcare sector clearly demonstrates just how "heavy" this industry is.
Book value of all companies included in the broad market index - GURU.Markets
DaVita's net worth is the largest network of thousands of outpatient dialysis centers in the United States. The company's book value directly reflects its vast portfolio of real estate and specialized medical equipment. The chart clearly demonstrates the physical weight of this leader in healthcare services.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - DaVita Inc.
DaVita's balance sheet is its massive network of dialysis centers. The market pays a premium for its dominant position (essentially a duopoly), stable demand driven by the chronic nature of the disease, and predictable cash flows. The chart is an assessment of this powerful and sustainable business model.
Market to book capitalization ratio in a market segment - Treatment
DaVita Inc. is one of the largest operators of dialysis centers in the United States. The company's business is based on owning and operating a network of clinics. The chart shows how investors value the stable and predictable cash flow from these services compared to the value of the medical infrastructure itself.
Market to book capitalization ratio for the market as a whole
DaVita is one of the largest dialysis center operators in the United States. The company owns an extensive network of clinics, which forms its financial base. Its market valuation also takes into account the stable demand for its vital services, driven by the chronic nature of kidney failure. The chart shows an assessment of this stability.
Debts of the company, segment and market as a whole
DVA - Company debts DaVita Inc.
DaVita Inc., one of the largest dialysis center operators, uses significant debt to finance its extensive network of clinics and acquire new centers. The business generates stable cash flows due to the chronic nature of the disease. This chart shows how the company uses leverage to expand its presence and dominate the dialysis market.
Market segment debts - Treatment
DaVita is one of the largest dialysis center operators in the United States. Providing medical services in this area requires a network of clinics and expensive equipment. Its debt burden reflects investments in expanding and maintaining this network. This chart shows how the company manages its finances in the regulated healthcare sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio DaVita Inc.
DaVita is one of the largest dialysis center operators in the US. This business generates stable cash flow but requires investment in clinics and equipment. This chart shows the company's debt level. It helps assess how effectively DaVita uses debt capital to expand its network and its financial risks.
Market segment debt to market segment book capitalization - Treatment
DaVita is one of the largest dialysis providers in the US. It is a stable business, dependent on government reimbursement programs. Debt can be used to open new clinics. The chart shows how the company's debt load relates to the overall capitalization and financial structure of the healthcare sector.
Debt to book value of all companies in the market
DaVita, a dialysis provider, has a stable yet capital-intensive business. This chart allows us to assess how significant its debt load is for opening clinics, compared not just to its competitors, but to the overall market capitalization and debt load of the entire stock market.
P/E of the company, segment and market as a whole
P/E - DaVita Inc.
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney disease in the United States. This chart illustrates how investors evaluate its business model. A stable metric often reflects the chronic nature of the disease and the ongoing need for treatment, which creates a predictable revenue stream.
P/E of the market segment - Treatment
DaVita is a dominant player in the dialysis services market. This chart shows the average valuation for the medical services sector. It provides insight into how investors value this stable but highly regulated business, and whether DaVita's valuation reflects its leadership and the demographic trends supporting demand for its services.
P/E of the market as a whole
DaVita is one of the largest dialysis center operators in the US. Demand for its services, unfortunately, is stable and growing due to the rise in kidney disease. This chart shows general market fluctuations. DaVita, however, presents a story based on demographics and the state of the healthcare system, making its business less dependent on short-term economic cycles.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company DaVita Inc.
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure in the United States. This chart reflects stable expectations based on the chronic nature of the disease and demographic trends. The dynamics show how the market is assessing changes in government reimbursement programs.
%20P%2FE%20DaVita%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-DaVita-Inc.&v=1771130134461 "Chart of the company's future (projected) P/E DaVita Inc.")
Future (projected) P/E of the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure in the United States. This chart reflects average profitability expectations for the sector. It provides insight into how the market perceives the company's business stability, due to the chronic nature of its disease, and the risks associated with government regulation.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Treatment&v=1771130134462 "Future (projected) P/E graph of the market segment - Treatment")
Future (projected) P/E of the market as a whole
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney failure in the United States. This chart illustrates overall market expectations. For a company operating in the healthcare sector with consistent demand driven by chronic conditions, it helps assess its stability against a backdrop of more volatile and cyclical economic sectors.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1771130134463 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit DaVita Inc.
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney failure in the United States. The financial results shown here are largely dependent on reimbursement rates from government programs such as Medicare. The chart reflects the stable demand for vital medical services driven by demographic factors.
Profit of companies in the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney failure in the United States. The company operates a network of outpatient dialysis centers. This chart shows the financial dynamics of the healthcare sector, where demographic factors such as an aging population and rising diabetes rates are driving steady demand for DaVita's services.
Overall market profit
DaVita is one of the largest providers of dialysis services for patients with kidney failure in the United States. Demand for its vital services is driven by demographic and medical factors, not the state of the economy. This makes the company's business extremely resilient and ensures a stable contribution to the healthcare sector and overall corporate profits.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company DaVita Inc.
DaVita is one of the largest providers of dialysis services for patients with end-stage renal disease in the United States. The profit projection shown in the graph depends on patient volume, reimbursement rates from government (Medicare) and private insurers, and effective cost management at the clinics.
%20profit%20of%20the%20company%20DaVita%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-DaVita-Inc.&v=1771130134472 "Graph of future (projected) profit of the company DaVita Inc.")
Future (predicted) profit of companies in the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney disease in the United States. The company's business is vital to its patients and is heavily dependent on government programs. This chart shows the revenue forecast for the treatment sector, allowing one to assess DaVita's operating efficiency in a complex regulatory environment.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Treatment&v=1771130134474 "Graph of future (predicted) profits of companies in a market segment - Treatment")
Future (predicted) profit of the market as a whole
DaVita Inc. is one of the largest dialysis providers in the United States. Demand for its services is driven by medical needs (the number of patients with kidney failure) and is not affected by economic cycles. However, as with other healthcare companies, the overall economy (schedule) influences government funding (Medicare).
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1771130134476 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - DaVita Inc.
DaVita is one of the largest dialysis providers in the US. This chart shows how the market values its revenue, which is heavily dependent on government reimbursement programs such as Medicare. This metric reflects stable demand due to the chronic nature of kidney disease.
P/S market segment - Treatment
DaVita Inc. is a leading provider of dialysis services for patients with chronic kidney disease in the United States. The company operates a network of outpatient dialysis centers, generating stable revenue. This chart shows the average valuation in the sector, providing insight into how investors view DaVita's business model in the specialty medical services sector.
P/S of the market as a whole
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney failure in the United States. The company operates a network of outpatient dialysis centers. This business is characterized by stable demand, supported by demographics. This chart helps understand how the market values healthcare providers with a predictable revenue model.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company DaVita Inc.
DaVita is one of the largest providers of dialysis services for patients with kidney failure in the United States. This chart shows how the market values the company relative to its future and projected sales. It reflects investor expectations for stable demand for vital dialysis services, driven by demographic factors.
%20P%2FS%20DaVita%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-DaVita-Inc.&v=1771130134483 "The graph of the company's future (projected) P/S DaVita Inc.")
Future (projected) P/S of the market segment - Treatment
DaVita Inc. is a leading provider of dialysis services for patients with chronic kidney disease in the United States. The company operates a large network of outpatient dialysis centers. It is a stable business supported by demographic trends. Its future revenue estimates in the healthcare services sector are presented here.
%20P%2FS%20market%20segment%20graph%20-%20Treatment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Treatment&v=1771130134485 "Future (projected) P/S market segment graph - Treatment")
Future (projected) P/S of the market as a whole
DaVita Inc. is one of the largest dialysis providers in the United States. Demand for its services is non-cyclical and driven by public health conditions, particularly the prevalence of chronic kidney disease. This general expectations chart for DVA is not a driver. The company's growth depends on demographic and medical trends, not the state of the economy.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1771130134486 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales DaVita Inc.
This chart demonstrates the stability and non-cyclical nature of the healthcare business. For DaVita, a leading dialysis provider, it reflects consistent revenue from its extensive network of outpatient centers. Treatment for kidney failure patients is covered by public and private insurance programs.
Sales of companies in the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with chronic kidney disease in the United States. The company's revenue depends on patient volume and Medicare reimbursement rates. This chart illustrates how rising diabetes rates and an aging population are impacting demand for DaVita's services and the entire specialized care sector.
Overall market sales
DaVita is one of the largest dialysis center operators in the United States. Demand for its vital services is stable and growing due to the rise in kidney disease. The company's business reflects the state of the healthcare system in the area of chronic diseases, which constitutes a significant and growing portion of economic expenditures.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company DaVita Inc.
DaVita is one of the largest providers of dialysis services for patients with kidney failure in the United States. The company's future revenue depends on demographic factors, the prevalence of chronic diseases, and government reimbursement policies. This chart shows expectations for the steadily growing healthcare sector.
%20sales%20of%20the%20company%20DaVita%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-DaVita-Inc.&v=1771130134494 "Schedule of future (projected) sales of the company DaVita Inc.")
Future (projected) sales of companies in the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure. The outlook for the chronic disease treatment sector is driven by demographics and lifestyle. It shows how an aging population and rising diabetes rates are creating continued demand for DaVita's vital services.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Treatment&v=1771130134495 "Schedule of future (projected) sales of companies in the market segment - Treatment")
Future (projected) sales of the market as a whole
DaVita Inc. is one of the largest providers of dialysis services in the United States for patients with kidney failure. Demand for these vital services is not dependent on economic cycles. The company's growth is driven by demographic and medical factors. However, the overall economic situation, as reflected here, affects government funding for the Medicare programs on which DaVita depends.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1771130134499 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality DaVita Inc.
DaVita, one of the largest dialysis providers in the US, demonstrates the resilience of its business model in this chart. Profitability depends on Medicare reimbursement and private insurance. The high demand for vital dialysis services ensures a stable flow of patients and revenue for the company.
Market segment marginality - Treatment
DaVita is one of the largest providers of dialysis services for patients with chronic kidney failure in the United States. This chart shows the average profitability in the healthcare sector. Stable and growing demand for vital dialysis services provides the company with predictable cash flow and allows it to maintain above-average margins.
Market marginality as a whole
#VALUE!
Employees in the company, segment and market as a whole
Number of employees in the company DaVita Inc.
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure in the United States. This chart illustrates the vast workforce of nurses and technicians working in thousands of its clinics. Steady staff growth reflects the steady increase in the number of patients requiring life-sustaining treatment, ensuring business predictability.
Share of the company's employees DaVita Inc. within the market segment - Treatment
DaVita Inc. is one of the two dominant providers of dialysis services for patients with chronic kidney failure in the United States. This chart illustrates its enormous contribution to healthcare. It reflects the huge share of nurses, dialysis technicians, and nephrologists DaVita employs nationwide to care for hundreds of thousands of patients in its clinics.
Number of employees in the market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure in the United States. This chart illustrates growth in the chronic disease sector. Demand for nurses and technicians at DaVita centers is steadily increasing due to the increasing prevalence of diabetes and hypertension, the leading causes of kidney disease.
Number of employees in the market as a whole
DaVita Inc. is one of the largest dialysis providers in the United States. Demand for its services is driven by chronic kidney disease and is not affected by economic cycles. However, the overall economic situation, reflected in the chart, affects government funding for Medicare programs, which account for the majority of the company's revenue.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company DaVita Inc. (DVA)
DaVita is one of two dominant dialysis providers in the US. This chart shows how the market values its business in the critical and stable healthcare sector. The dynamics of market capitalization per employee (nurse, technician) reflects the company's ability to effectively manage thousands of clinics and provide vital services to millions of patients.
%20of%20the%20company%20DaVita%20Inc.%20(DVA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-DaVita-Inc.-DVA&v=1771130134506 "Chart of market capitalization per employee (in thousands of dollars) of the company DaVita Inc. (DVA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Treatment
DaVita Inc. is a leading provider of kidney failure treatment services, operating thousands of dialysis centers in the US and around the world. It is a labor-intensive healthcare service. This chart shows the average market capitalization per employee in the sector. It helps assess how effectively the market perceives DaVita to manage its clinics and numerous medical staff.
%20by%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Treatment&v=1771130134506 "Market capitalization per employee (in thousands of dollars) by market segment - Treatment")
Market capitalization per employee (in thousands of dollars) for the overall market
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure. It's a vital medical service with constant demand. This chart shows how the market values the operator in the labor-intensive healthcare sector, where a large network of clinics and qualified medical staff are the foundation of its business.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1771130134507 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company DaVita Inc. (DVA)
DaVita is one of the two dominant providers of dialysis (a treatment for kidney failure) in the United States. Their business is a network of thousands of outpatient centers. This is a vital but labor-intensive medical service. This metric is critical for DaVita. It shows how much profit (heavily dependent on Medicare rates) each nurse and technician generates by caring for patients on dialysis machines.
%20Chart%20DaVita%20Inc.%20(DVA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-DaVita-Inc.-DVA&v=1771130134509 "Company Profit Per Employee (in thousands of dollars) Chart DaVita Inc. (DVA)")
Profit per employee (in thousands of dollars) in the market segment - Treatment
DaVita (DVA) is a leader in dialysis centers (kidney treatment). This chart shows the benchmark for "Treatment." Average profit per employee in this sector is extremely low. This is a labor-intensive "offline" business (nurses, clinics). The benchmark reflects the efficiency of "bed" management and is entirely dependent on Medicare rates.
%20in%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Treatment&v=1771130134510 "Chart of profit per employee (in thousands of dollars) in the market segment - Treatment")
Profit per employee (in thousands of dollars) for the market as a whole
DaVita is one of the largest dialysis center operators in the United States. Providing medical services for the treatment of chronic kidney failure is a labor-intensive process that requires qualified medical personnel. This chart shows how profitability in this field is directly dependent on government tariffs and the operational efficiency of each clinic.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1771130134513 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee DaVita Inc. (DVA)
DaVita is one of the largest dialysis center operators in the US. This chart reflects the productivity of its clinics. It measures the revenue generated by each employee, from nurses to administrators. This is a key performance indicator in the labor-intensive healthcare sector, dependent on patient volume and reimbursement rates.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-DaVita-Inc.-DVA&v=1771130134514 "Sales chart per company employee DaVita Inc. (DVA)")
Sales per employee in the market segment - Treatment
DaVita Inc. is one of the largest dialysis center operators in the United States. It's a critically important but labor-intensive healthcare business. This metric reflects how effectively their clinics and medical staff deliver vital services. It allows them to assess their operational performance in an environment of strict regulations and reliance on Medicare reimbursement.
Sales per employee for the market as a whole
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure in the United States. They operate a network of outpatient dialysis centers. It's a labor-intensive healthcare business. This chart shows how much revenue each employee (nurses, technicians) generates. It reflects the efficiency of center management and the complex reimbursement system (primarily from Medicare).
Short shares by company, segment and market as a whole
Shares shorted by company DaVita Inc. (DVA)
DaVita Inc. is one of two dominant providers of dialysis services for kidney failure patients in the US (along with Fresenius). This chart shows bearish sentiment. Bears have long pointed out the risks associated with the company's reliance on government payments (Medicare) and potential regulatory changes aimed at reducing the cost of dialysis procedures.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-DaVita-Inc.-DVA&v=1771130134518 "Short Shares Chart for the Company DaVita Inc. (DVA)")
Shares shorted by market segment - Treatment
DaVita Inc. is one of the largest providers of dialysis services for patients with kidney failure. Their business is heavily dependent on Medicare rates. This chart shows the overall short position in the healthcare services sector (dialysis). The high short position in the industry signals that investors are concerned about government pressure on reimbursement rates, which would hurt all players.
Shares shorted by the overall market
DaVita is part of a duopoly (along with Fresenius) in the dialysis center market. Their business is entirely dependent on Medicare payments. This chart reflects the bets on disrupting their model. Bears are shorting DVA, fearing two things: a decline in government dialysis rates or the emergence of new drugs (such as GLP-1) that treat diabetes and kidney disease, reducing the need for dialysis.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator DaVita Inc. (DVA)
DaVita is the market leader in dialysis centers in the US. Its business depends on Medicare reimbursement rates and patient volume. This chart shows a DVA above 70, which may reflect revenue stability. A DVA below 30 is often associated with concerns about reduced government funding or regulatory pressure on the industry.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-DaVita-Inc.-DVA&v=1771130134521 "RSI 14 indicator chart for the company's stock DaVita Inc. (DVA)")
RSI 14 Market Segment - Treatment
DaVita (DVA) is one of the two leaders (along with Fresenius) in providing dialysis services (artificial kidney) in the US. The RSI_14_Seg for "Treatment" shows the "temperature" of the sector. It helps us understand whether DVA's growth reflects operational efficiency or general "overheating" in the healthcare sector.
RSI 14 for the overall market
DaVita Inc. is one of the largest dialysis providers in the US. Their business is vital for patients but is heavily dependent on government reimbursements (Medicare). This market sentiment chart shows how investors assess regulatory risks. During times of panic, the healthcare sector may appear defensive, but market euphoria often bypasses it due to political uncertainty.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast DVA (DaVita Inc.)
DaVita is one of the two dominant providers of dialysis (kidney failure treatment) in the US. Their business consists of thousands of outpatient dialysis centers. This chart shows the average 12-month target from analysts. It reflects their forecasts for procedure volume and, crucially, reimbursement levels from private and government insurance.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-DVA-DaVita-Inc.&v=1771130134525 "A chart showing analyst consensus forecasts for the expected stock price. DVA (DaVita Inc.)")
The difference between the consensus estimate and the actual stock price DVA (DaVita Inc.)
DaVita is one of two dominant providers of dialysis services for patients with kidney failure in the United States. Its business is heavily dependent on Medicare reimbursement rates. This chart shows the gap between the market's current valuation of DaVita and analysts' perceptions of its value. This reflects their views on future rates and demographics.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-DVA-DaVita-Inc.&v=1771130134526 "A chart showing the difference between the consensus forecast and the actual stock price. DVA (DaVita Inc.)")
Analyst consensus forecast for stock prices by market segment - Treatment
DaVita is one of two giants (along with Fresenius) in the US dialysis center market. The company's business is critical for patients, but it is highly dependent on Medicare rates. This chart shows analysts' overall expectations for the treatment sector. It reflects whether experts believe the dialysis business is stable or whether they see regulatory risks.
Analysts' consensus forecast for the overall market share price
DaVita Inc. is part of a duopoly (along with Fresenius) in the US dialysis clinic market. Their business is a non-cyclical demand funded by the government (Medicare). Market expectations, as seen in this chart, don't affect their demand. However, they do impact inflation (nurses' salaries) and rates, which puts significant pressure on their margins.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index DaVita Inc.
DaVita is one of two dominant players (along with Fresenius) in the US dialysis center market. They provide vital services to patients with kidney failure. This chart reflects their complex business model. It depends on demographics (patient growth) but is extremely sensitive to reimbursement rates from Medicare and private insurers.
AKIMA Market Segment Index - Treatment
DaVita is one of two (along with Fresenius) dominant dialysis providers (a treatment for kidney failure) in the United States. It's a vital service, paid primarily by Medicare. This aggregate metric evaluates companies. The chart shows the average value for the care sector. This benchmark: how does this dialysis duopoly, DaVita, differentiate itself from the average competitor?
The AKIM Index for the overall market
DaVita is one of the two dominant companies (along with Fresenius) in the provision of dialysis (artificial kidney) services in the US. It's a defensive business. This chart, reflecting the market average, is a backdrop. It helps assess how DaVita, which is dependent on Medicare rates, compares to the overall macroeconomic fluctuations reflected by this indicator.
